| 000 | 01784 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517132422.0 | ||
| 264 | 0 | _c20180409 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1938-0690 | ||
| 024 | 7 |
_a10.1016/j.cllc.2016.11.018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLynch, Julie A | |
| 245 | 0 | 0 |
_aEpidermal Growth Factor Receptor Mutational Testing and Erlotinib Treatment Among Veterans Diagnosed With Lung Cancer in the United States Department of Veterans Affairs. _h[electronic resource] |
| 260 |
_bClinical lung cancer _c07 2017 |
||
| 300 |
_a401-409 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdiagnosis |
| 650 | 0 | 4 |
_aDNA Mutational Analysis _xmethods |
| 650 | 0 | 4 |
_aErbB Receptors _xgenetics |
| 650 | 0 | 4 |
_aErlotinib Hydrochloride _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGuideline Adherence |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Department of Veterans Affairs |
| 650 | 0 | 4 | _aVeterans |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBerse, Brygida | |
| 700 | 1 | _aChun, Danielle | |
| 700 | 1 | _aRivera, Donna | |
| 700 | 1 | _aFilipski, Kelly K | |
| 700 | 1 | _aKulich, Scott | |
| 700 | 1 | _aViernes, Benjamin | |
| 700 | 1 | _aDuVall, Scott L | |
| 700 | 1 | _aKelley, Michael J | |
| 773 | 0 |
_tClinical lung cancer _gvol. 18 _gno. 4 _gp. 401-409 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cllc.2016.11.018 _zAvailable from publisher's website |
| 999 |
_c26743305 _d26743305 |
||